Evidence map›Paper›PMID 40455724›Full record

ArticlePloS one2025

Utility of artificial intelligence-based conversation voice analysis for detecting cognitive decline.

Takeshi Kuroda, Kenjiro Ono, Masaki Onishi, Kouzou Murakami, Daiki Shoji, Shota Kosuge, Atsushi Ishida, Sotaro Hieda, Masato Takahashi, Hisashi Nakashima and 2 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Takeshi KurodaDepartment of Neurology, Showa University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5730-7415
Kenjiro OnoDepartment of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Masaki OnishiExaWizards Inc., Tokyo, Japan.
Kouzou MurakamiDepartment of Radiology, Showa University School of Medicine, Tokyo, Japan.
Daiki ShojiDepartment of Neurology, Showa University School of Medicine, Tokyo, Japan.
Shota KosugeDepartment of Neurology, Showa University School of Medicine, Tokyo, Japan.
Atsushi IshidaDepartment of Neurology, Showa University School of Medicine, Tokyo, Japan.
Sotaro HiedaDepartment of Neurology, Showa University School of Medicine, Tokyo, Japan.
Masato TakahashiExaWizards Inc., Tokyo, Japan.
Hisashi NakashimaExaWizards Inc., Tokyo, Japan.
Yoshinori ItoDepartment of Radiology, Showa University School of Medicine, Tokyo, Japan.
Hidetomo MurakamiDepartment of Neurology, Showa University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent developments in artificial intelligence (AI) have introduced new technologies that can aid in detecting cognitive decline. This study developed a voice-based AI model that screens for cognitive decline using only a short conversational voice sample. The process involved collecting voice samples, applying machine learning (ML), and confirming accuracy through test data. The AI model extracts multiple voice features from the collected voice data to detect potential signs of cognitive impairment. Data labeling for ML was based on Mini-Mental State Examination scores: scores of 23 or lower were labeled as "cognitively declined (CD)," while scores above 24 were labeled as "cognitively normal (CN)." A fully coupled neural network architecture was employed for deep learning, using voice samples from 263 patients. Twenty voice samples, each comprising a one-minute conversation, were used for accuracy evaluation. The developed AI model achieved an accuracy of 0.950 in discriminating between CD and CN individuals, with a sensitivity of 0.875, specificity of 1.000, and an average area under the curve of 0.990. This voice AI model shows promise as a cognitive screening tool accessible via mobile devices, requiring no specialized environments or equipment, and can help detect CD, offering individuals the opportunity to seek medical attention.

Indexed as

Artificial IntelligenceCognitive DysfunctionVoiceAgedAged, 80 and overDeep LearningFemaleHumansMachine LearningMaleMiddle AgedNeural Networks, Computer

Identifiers

PMID40455724
PMCPMC12129157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.